Insmed | INSM - Capitalización De Mercado

Precio De Mercado
136.00
Cambio Diario
-8.00 -5.56%
Mensual
-14.48%
Anual
70.17%
Q1 Expectativa
131.92




Capitalización De Mercado Cambio Fecha
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Cytokinetics USD 7.77B 1.19B 2025-12
DBV Technologies USD 745M 471M 2026-03
Gilead Sciences USD 152.28B 14.55B 2025-12
Heron Therapeutics USD 133M 105M 2026-03
Insmed USD 37.12B 6.68B 2025-12
Novartis USD 303.66B 40.58B 2026-03
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12